tiprankstipranks
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ:TSHA
US Market
TSHA
Taysha Gene Therapies
RESEARCH TOOLSreports
Want to see TSHA full AI Analyst Report?

Taysha Gene Therapies (TSHA) Stock News & Sentiment

1,257 Followers
ASPIRE Rett Syndrome Trial Puts Taysha’s TSHA-102 Gene Therapy in Focus for Investors
Premium
Company Announcements
ASPIRE Rett Syndrome Trial Puts Taysha’s TSHA-102 Gene Therapy in Focus for Investors
3d ago
TSHA
Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA
Premium
Company Announcements
Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA
14d ago
TSHA
Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway
Premium
Ratings
Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway
18d ago
TSHA
Buy Rating on Taysha Gene Therapies Driven by Strong Leadership, Strategic Positioning, and Attractive Risk‑Reward Upside
Premium
Ratings
Buy Rating on Taysha Gene Therapies Driven by Strong Leadership, Strategic Positioning, and Attractive Risk‑Reward Upside
1M ago
TSHA
Advancing Gene Therapy Programs and Strengthened Valuation Support Taysha Buy Rating and $17 Target
Premium
Ratings
Advancing Gene Therapy Programs and Strengthened Valuation Support Taysha Buy Rating and $17 Target
2M ago
TSHA
Taysha Gene Therapies Signals Momentum in Earnings Call
Premium
Company Announcements
Taysha Gene Therapies Signals Momentum in Earnings Call
2M ago
TSHA
TSHA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TSHA Earnings this Week: How Will it Perform?
3M ago
TSHA
More TSHA News >

TSHA News on the Web

FDA Commissioner Marty Makary resigns
TipRanks News
Neutral
Taysha Gene Therapies Ramps Up Ahead of TSHA-102 BLA
TipRanks News
Bullish
Bank of America Securities Sticks to Its Buy Rating for Taysha Gene Therapies (TSHA)
TipRanks News
Bullish
Whitney Ijem Reiterates Buy Rating and Maintains $17 Price Target on Clinical Momentum and Strong Cash Runway
TipRanks News
Bullish
Wells Fargo Keeps Their Buy Rating on Taysha Gene Therapies (TSHA)
TipRanks News
Bullish
Taysha Gene Therapies reports Q1 EPS (12c), consensus (10c)
TipRanks News
Bullish
Chardan Capital Remains a Buy on Taysha Gene Therapies (TSHA)
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
TSHA
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.25 articles
News Sentiment
This Week99%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSHA’s Media Buzz Sentiment?
2 articles about TSHA were published this week. In an average week, 2.25 articles are published.
    What is TSHA’s weekly average amount of articles?
    In an average week, 2.25 articles about TSHA are published.
      What is TSHA’s News Sentiment?
      99% of articles about TSHA were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week